TSCO
48
-3
FLR
56
-2
ISRG
74
3
RF
67
-2
MSFT
57
6
LEN
57
-4
DAL
79
-4
PSX
50
3
O
24
2
FCX
57
-2
WBA
51
-3
WMT
79
3
SWKS
51
-2
V
72
-4
PM
66
4
LEG
43
-7
WHR
65
-7
EXPE
93
2
VFC
50
-2
WAT
64
7
TSCO
48
-3
FLR
56
-2
ISRG
74
3
RF
67
-2
MSFT
57
6
LEN
57
-4
DAL
79
-4
PSX
50
3
O
24
2
FCX
57
-2
WBA
51
-3
WMT
79
3
SWKS
51
-2
V
72
-4
PM
66
4
LEG
43
-7
WHR
65
-7
EXPE
93
2
VFC
50
-2
WAT
64
7
Financhill
Back

Innate Pharma SA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
10

IPHA
Innate Pharma SA

Last Price:
1.50
Seasonality Move:
6.04%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
134.73
Seasonality Move:
14.88%
Sell
10
Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

  • The current Innate Pharma SA [IPHA] share price is $1.50. The Score for IPHA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • IPHA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

  • The Innate Pharma SA share price today is $1.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

IPHA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 39.39 Sell
Chaikin Money Flow: 9225 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.58 - 1.9) Sell
Bollinger Bands (100): (1.85 - 2.31) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

IPHA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Sell
20-day SMA: 1.72 Sell
50-day SMA: 1.94 Sell
200-day SMA: 2.29 Sell
8-day EMA: 1.58 Sell
20-day EMA: 1.69 Sell
50-day EMA: 1.88 Sell
200-day EMA: 2.23 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Innate Pharma SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):